Long-Term Safety and Efficacy of ABP 501 in Patients With RA Long-Term Safety and Efficacy of ABP 501 in Patients With RA

How does the safety and efficacy of the adalimumab biosimilar ABP 501 compare with that of the reference product?Arthritis Research & Therapy
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology Journal Article Source Type: news